Skip to Content
Merck
CN
  • Silyl Modification of Biologically Active Compounds. 10. Lipid Type Organosilicon Derivatives of 8-Hydroxyquinoline and N-(2-Hydroxyethyl)-1, 2, 3, 4-tetrahydro (sila, iso) quinolines.

Silyl Modification of Biologically Active Compounds. 10. Lipid Type Organosilicon Derivatives of 8-Hydroxyquinoline and N-(2-Hydroxyethyl)-1, 2, 3, 4-tetrahydro (sila, iso) quinolines.

Chemistry of Heterocyclic Compounds (2005)
Segal I, et al.